Microscopic polyangiitis with eosinophilia - An overlap syndrome or a separate disease entity?;Mikroskopische Polyangiitis mit Eosinophilie - Uberlappungssyndrom oder eigenstandiges Krankheitsbild?

Hautarzt

Volumn 48, Issue 5, 1997, Pages 332-338

  Weninger, Wolfgang ^a   Kain, Renate ^b   Tschachler, Erwin ^a   Stingl, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Inst für Klinische Pathologie   (Austria)

Author keywords

ANCA; eosinophils; pyoderma gangrenosum; vasculitis; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; EOSINOPHILIA; FEMALE; FEVER; HEMOPTYSIS; HUMAN; PYODERMA GANGRENOSUM; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; PYODERMA GANGRENOSUM; SKIN; VASCULITIS, ALLERGIC CUTANEOUS; WEGENER GRANULOMATOSIS;

EID: 0030962969     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050592     Document Type: Article

References (48)

1. Adebajo AO, Charles P, Maint RN, Hazleman BL (1993) Autoantibodies in tuberculosis, malaria and hepatitis B in a west African population. Clin Exp Immunol 92:73-76
2. Alarcon-Segovia D, Brown AL Jr (1964) Classification and etiologic aspects of necrotizing angiitis: an analytical approach to a confused subject with a critical review of the evidence for hypersensitivity in polyarteritis nodosa. Mayo Clin Proc 39:205-222
3. Bloch AB, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis: patients and methods. Arthritis Rheum 33:1068-1073
4. Bloch DA, Lincoln EM, Michel BA (1990) Statistical approaches to classification: methods for developing classification and other criteria rules. Arthritis Rheum 33:1137-1144
5. Callen JP (1993) Cutaneous vasculitis: relationship to systemic disease and therapy. Curr Prob Dermatol 2:47-80
6. Cohen Tervaert JWC, Huitem MG, Hene RJ (1990) Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibodies. Lancet 336:709-711
7. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95 244-250
8. Davies DJ, Moran JE, Niall JF, Ryan GB (1982) Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus etiology. Br Med J 2:606-609
9. Davson J, Ball J, Platt R (1948) The kidney in periarteritis nodosa.Q J Med 17:175-202
10. DeShazo RD (1975) The spectrum of systemic vasculitis: a classification to aid diagnosis. Postgrad Med 58 78-84
11. Falk RJ, Jennette JC (1988) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N Engl J Med 318:1651-1657
12. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119
13. Fauci AS, Haynes BF, Katz P (1978) The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 89:660-676
14. Fauci AS, Katz P, Haynes BF, Wolff SM (1979) Cyclophosphamide therapy of severe necrotizing vasculitis. N Engl J Med 67:941-947
15. Frances C, Du LT, Piette JC, Saada V, Boisnic S, Wechsler B, Bletry O, Godeau P (1994) Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 130:861-867
16. Gilliam JM, Smiley JD (1976) Cutaneous necrotizing vasculitis and related disorders. Ann Allergy 37 328-339
17. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon BA (1993) Relapses in patients with systemic vasculitis. Q J Med 86:779-789
18. Gravallese EM (1994) Systemic vasculitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine. McGraw-Hill, New York, pp 2167-2178
19. Gross WL (1993) Klassifikation nekrotisierender Vaskulitiden. Internist 34:599-614
20. Gross WL, Schmitt WH, Csernok E (1993) ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91:1-12
21. Gross WL (1994) New developments in the treatment of systemic vasculitis. Curr Opin Rheum 6:11-19
22. Gross WL, Csernok E (1995) Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheum 7:11-19
23. Guillevin L, Lhote F (1995) Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheum 7:20-24
24. Hall S, Conn DL (1995) Immunosuppressive therapy for vasculitis. Curr Opin Rheum 7:25-29
25. Haynes BF (1992) Pathogenic mechanisms of vessel damage. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation, basic principles and clinical correlates. Raven, New York, pp 921-941
26. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488-498
27. Jayne DRW, Davies MJ, Fox CIV, Black CM, Lockwood CM (1991) Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337:1137-1139
28. Jennette JC, Falk RJ (1992) Disease associations and pathogenic role of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheum 4:9-15
29. Jennette JC, Falk WJ, Andrassy K, Bacon BA, Chur J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van ES LA, Waldherr R, Wilk A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 187-192
30. Katz P, Fauci AS (1988) Systemic vasculitis. In: Samter M, Talmage DW, Frank MM, Austen KF, Claman HN (eds) Immunological diseases (eds) Little Brown, Boston Toronto, pp 1417-1435
31. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS (1993) Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36:365-371
32. Klaassen RJL, Goldschmeding R, Dolman KM, Vlekke ABJ, Weigel HM, Eeftnick Schattenkerk JKM, Mulder JW, Westedt ML, von dem Borne AEG (1992) Anti-neutrophil cytoplasmic antibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87:24-30
33. Krupsky M, Landau Z, Lifschitz-Merzer B, Resnitzky P (1993) Wegener's granulomatosis with peripheral eosinophilia. Atypical variant of a classical disease. Chest 104:1290-1292
34. Leevitt RY, Fauci AS (1986) Polyangiitis overlap syndrome: classification and prospective clinical experience. Am J Med 81:79-85
35. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WB, Calabrese LH, Edworthy SM, Fries JF, Lie JT, Lightfoot RW, Masi At, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American-College-of-Rheumatology 1990 criteria for the classification of Wegener granulomatosis. Arthritis Rheum 33:1101-1107
36. Lightfoot RW (1994) Overview of the inflammatory vascular diseases. In: Klippel JH (ed) Rheumatology. Mosby-Year Book, UK, pp 6/16.1
37. Lie JT (1990) Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 33:1074-1087
38. Lie JT (1994) Nomenclature and classification of vasculitis: plus ca change, plus c'est la même chose. Arthritis Rheum 37:181-186
39. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WB, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW, McShane DJ, Mills JA, Stevens MS, Wallace SL, Zvaifler NJ (1990) The American-College-of-Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome. Arthritis Rheum 33:1094-1100
40. Niles JL (1993) Value of tests for antineutrophil cytoplasmic antibodies in the diagnosis and treatment of vasculitis. Curr Opin Rheum 5:18-24
41. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL (1994) Influence of disease manifestation and cANCA titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 6:919-924
42. Richter C, Schnabel A, Csernok E, Reinhold-Keller E, Gross WL (1993) Treatment of Wegener's granulomatosis with intravenous immunoglobulin. In: Gross WL (ed) ANCA associated vasculitides: immunological and clinical aspects Plenum Press, London
43. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL (1992) Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: association with disease activity. Arthritis Rheum 35:1088-1096
44. Schwartz RA, Churg J (1992) Churg-Strauss syndrome. BrJ Dermatol 127:199-204
45. Soto A, Jorgensen C, Oksman F, Noel LH, Sany J (1994) Endocarditis associated with ANCA. Clin Exp Rheum 12:203-204
46. van der Woude, Rasmussen N, Lobatto S, Wiik A, Permin H, van ES LA, van der Giessen M, van der HEM GK (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-9
47. Wolff K and Stingl G (1994) Pyoderma gangrenosum. In. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine. McGraw-Hill, New York, pp 1171-1182
48. Yousem SA, Lombard CM (1988) The eosinophilic variant of Wegener's granulomatosis. Hum Pathol 19:682-688